OUP Management Co., LLC

Concentrated strategyLong-term holderQuality / disciplined sizing

Total reported value

$44.5M

Reporting period: 2023-09-30 · Number of holdings: 12

OUP Management Co., LLC disclosed 12 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of $44.5M and a quarterly turnover rate of 0.0%.

Browse other institutions with under $100M AUM Browse other institutions starting with "O"

Personality snowflake

Concentration: 100
Portfolio Stability: 0
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 24
Sizing Uniformity: 84.73

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	260	Centessa Pharmaceuticals-adr	Stock-Other	42.74%	—	—
2	✓		Stock-Other	18.43%	—	—
3	✓		Stock-Other	15.71%	—	—
4	PMVP	Pmv Pharmaceuticals INC	Stock-Other	13.66%	—	—
5	GRPH	Graphite Bio INC	Stock-Other	2.27%	—	—
6	SELBUSD	Cartesian Therapeutics INC	Stock-Other	2.06%	—	—
7	VOR	Vor Biopharma Inc.	Stock-Other	1.79%	—	—
8	✓	Effector Therapeutics INC	Stock-Other	1.38%	—	—
9	✓		Stock-Other	0.86%	—	—
10	SPRO	Spero Therapeutics INC	Stock-Other	0.68%	—	—
11	✓	Ikena Oncology INC	Stock-Other	0.26%	—	—
12	FIXXEUR	Homology Medicines INC	Stock-Other	0.17%	—	—

Portfolio Performance

Not enough priced holdings yet to compute performance

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Top holdings
2023-09-30	12	$44.5M	12602008064323284P Top holdings2023-09-30 1.260 2.008064 3.23284P 4.PMVP 5.GRPH 6.SELBUSD 7.VOR 8.28202V 9.74019P 10.SPRO
2023-06-30	12	$58.6M	1260223345J3008064 Top holdings2023-06-30 1.260 2.23345J 3.008064 4.23284P 5.PMVP 6.VOR 7.GRPH 8.SELBUSD 9.28202V 10.74019P
2023-03-31	14	$50.1M	10080642260323345J Top holdings2023-03-31 1.008064 2.260 3.23345J 4.PMVP 5.23284P 6.IONQ 7.VOR 8.PRME 9.SELBUSD 10.GRPH
2022-12-31	14	$61.3M	10080642260 3PMVP Top holdings2022-12-31 1.008064 2.260 3.PMVP 4.23345J 5.IONQ 6.23284P 7.VOR 8.PRME 9.GRPH 10.74019P
2022-09-30	15	$64.2M	1260 2PMVP323345J Top holdings2022-09-30 1.260 2.PMVP 3.23345J 4.008064 5.IONQ 6.23284P 7.VOR 8.74019P 9.SELBUSD 10.EVLV
2022-06-30	15	$72.7M	1260 2PMVP3008064 Top holdings2022-06-30 1.260 2.PMVP 3.008064 4.23345J 5.23284P 6.IONQ 7.EVLV 8.VOR 9.74019P 10.28202V
2022-03-31	16	$131.3M	1IONQ 2260 3PMVP Top holdings2022-03-31 1.IONQ 2.260 3.PMVP 4.008064 5.23345J 6.23284P 7.EVLV 8.28202V 9.74019P 10.515069
2021-12-31	16	$221.9M	1IONQ223284P3260 Top holdings2021-12-31 1.IONQ 2.23284P 3.260 4.PMVP 5.23345J 6.515069 7.28202V 8.74019P 9.EVLV 10.008064

Holding changes this quarter

Position changes disclosed by OUP Management Co., LLC for the quarter ending 2023-09-30, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action

FAQ

What is OUP Management Co., LLC and what type of investor is it?

OUP Management Co., LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-09-30), the firm manages a tracked equity portfolio valued at approximately $44.5M, spread across 12 disclosed positions.

What are OUP Management Co., LLC's largest equity positions?

Based on the latest 13F filing, OUP Management Co., LLC's top holdings by market value are: 1. Centessa Pharmaceuticals-adr (260) — $19.0M (42.7%) 2. — $8.2M (18.4%) 3. — $7.0M (15.7%) 4. Pmv Pharmaceuticals INC (PMVP) — $6.1M (13.7%) 5. Graphite Bio INC (GRPH) — $1.0M (2.3%)

What changes did OUP Management Co., LLC make in its most recent portfolio filing?

No notable portfolio changes were recorded for OUP Management Co., LLC in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does OUP Management Co., LLC focus on?

Sector breakdown data is not yet available for OUP Management Co., LLC. Check back after the next 13F processing cycle.